drugset / Trial / NCT03028285

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

NCT03028285

RandomizedParallel-groupOpen-labelTreatment

Summary

Unifusol (R) is a solution of arginine sodium succinate for intravenous infusions. Its effects include vasodilation, protection of inner layer of blood vessels and improvement of blood viscosity. The present phase I study is aimed to evaluate the safety and tolerability of Unifusol infusions in healthy volunteers.

Timeline

Start
2016-07-15
Primary completion
2017-01-19
Completion
2017-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 250 ml Intravenous
Subject L-arginine Small molecule 500 ml Intravenous